Cargando…
Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey
BACKGROUND: Coronavirus disease 2019 (COVID-19) can affect the neurological as well as the respiratory system. Neurological manifestations may involve the central or peripheral nervous systems, or musculoskeletal system. Findings can range from mild presentations, such as headache and anosmia, to se...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321161/ https://www.ncbi.nlm.nih.gov/pubmed/37551396 http://dx.doi.org/10.2478/abm-2022-0004 |
_version_ | 1785068569701122048 |
---|---|
author | Usta, Nuray Can Kartal, Seyfi Gunay, Betul Onal Boz, Cavit |
author_facet | Usta, Nuray Can Kartal, Seyfi Gunay, Betul Onal Boz, Cavit |
author_sort | Usta, Nuray Can |
collection | PubMed |
description | BACKGROUND: Coronavirus disease 2019 (COVID-19) can affect the neurological as well as the respiratory system. Neurological manifestations may involve the central or peripheral nervous systems, or musculoskeletal system. Findings can range from mild presentations, such as headache and anosmia, to severe complications, such as stroke and seizure. OBJECTIVES: To evaluate the neurological findings and to determine etiological risk factors for mortality in patients hospitalized for COVID-19. METHODS: Medical records of patients with COVID-19 who were hospitalized and sought neurological consultation between March 2020 and March 2021 at a reference pandemic hospital in Turkey were reviewed retrospectively in a cross-sectional study design. RESULT: We included data from 150 (94 male) patients. Their mean age ± standard deviation was 68.56 ± 16.02 (range 21–97) years. The patients were categorized into 2 groups according to any acute neurological event or progression of neurological disease. Ischemic cerebrovascular events, seizures, and encephalopathy were the most common acute neurological events, while deterioration in consciousness, epileptic seizures, and Parkinson disease were observed in those with progression of neurological disease. Abnormal neurological findings were found at a mean of 7.8 ± 9.7 days following COVID-19 diagnosis and 50 (a third of) patients died. A logistic regression model found that advanced age, increased Modified Charlson Comorbidity Index (MCCI) score, and prolonged duration of hospitalization were factors significantly associated with increased mortality; however, sex and day of abnormal neurological findings after COVID-19 diagnosis were not. Common conditions accompanying neurological events were hypertension, coronary artery disease–heart failure, and diabetes mellitus. CONCLUSION: COVID-19 may present with neurological symptoms in our Turkish patients and comorbidities are often present. |
format | Online Article Text |
id | pubmed-10321161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Sciendo |
record_format | MEDLINE/PubMed |
spelling | pubmed-103211612023-08-07 Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey Usta, Nuray Can Kartal, Seyfi Gunay, Betul Onal Boz, Cavit Asian Biomed (Res Rev News) Original Article BACKGROUND: Coronavirus disease 2019 (COVID-19) can affect the neurological as well as the respiratory system. Neurological manifestations may involve the central or peripheral nervous systems, or musculoskeletal system. Findings can range from mild presentations, such as headache and anosmia, to severe complications, such as stroke and seizure. OBJECTIVES: To evaluate the neurological findings and to determine etiological risk factors for mortality in patients hospitalized for COVID-19. METHODS: Medical records of patients with COVID-19 who were hospitalized and sought neurological consultation between March 2020 and March 2021 at a reference pandemic hospital in Turkey were reviewed retrospectively in a cross-sectional study design. RESULT: We included data from 150 (94 male) patients. Their mean age ± standard deviation was 68.56 ± 16.02 (range 21–97) years. The patients were categorized into 2 groups according to any acute neurological event or progression of neurological disease. Ischemic cerebrovascular events, seizures, and encephalopathy were the most common acute neurological events, while deterioration in consciousness, epileptic seizures, and Parkinson disease were observed in those with progression of neurological disease. Abnormal neurological findings were found at a mean of 7.8 ± 9.7 days following COVID-19 diagnosis and 50 (a third of) patients died. A logistic regression model found that advanced age, increased Modified Charlson Comorbidity Index (MCCI) score, and prolonged duration of hospitalization were factors significantly associated with increased mortality; however, sex and day of abnormal neurological findings after COVID-19 diagnosis were not. Common conditions accompanying neurological events were hypertension, coronary artery disease–heart failure, and diabetes mellitus. CONCLUSION: COVID-19 may present with neurological symptoms in our Turkish patients and comorbidities are often present. Sciendo 2022-02-28 /pmc/articles/PMC10321161/ /pubmed/37551396 http://dx.doi.org/10.2478/abm-2022-0004 Text en © 2022 Nuray Can Usta et al., published by Sciendo https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. |
spellingShingle | Original Article Usta, Nuray Can Kartal, Seyfi Gunay, Betul Onal Boz, Cavit Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey |
title | Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey |
title_full | Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey |
title_fullStr | Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey |
title_full_unstemmed | Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey |
title_short | Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey |
title_sort | neurological manifestations and etiological risk factors in patients hospitalized with covid-19 in turkey |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321161/ https://www.ncbi.nlm.nih.gov/pubmed/37551396 http://dx.doi.org/10.2478/abm-2022-0004 |
work_keys_str_mv | AT ustanuraycan neurologicalmanifestationsandetiologicalriskfactorsinpatientshospitalizedwithcovid19inturkey AT kartalseyfi neurologicalmanifestationsandetiologicalriskfactorsinpatientshospitalizedwithcovid19inturkey AT gunaybetulonal neurologicalmanifestationsandetiologicalriskfactorsinpatientshospitalizedwithcovid19inturkey AT bozcavit neurologicalmanifestationsandetiologicalriskfactorsinpatientshospitalizedwithcovid19inturkey |